Navigation Links
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Date:3/20/2009

TUSTIN, Calif., November 23, 2008 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal models of two lethal viruses--cytomegalovirus and Lassa fever virus, a hemorrhagic fever virus that is listed as a class A bioterrorism agent by the CDC. Bavituximab showed potent anti-viral activity in both models.

Dr. Melina Soares, lead study author and UT Southwestern instructor of pharmacology, commented, "Recent non-affiliated research has further confirmed that exposed PS has immunosuppressive properties and is also clarifying its involvement during vi
'/>"/>

Contact: Barbara Lindheim
blindheim@biocompartners.com
212-918-4650
BioCom Partners
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nature Reviews Publishes Article About Jennerexs Multi-Mechanistic Cancer Therapeutic
2. Light-speed nanotech: Controlling the nature of graphene
3. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
4. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
5. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
6. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
7. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
8. Genetic clock makers at UC San Diego publish their timepiece in Nature
9. James L. Wittliff, Ph.D., FACB, to Present Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System at the Association for Molecular Pathology Conference, October 30
10. Natures Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity
11. DOE JGI Director Eddy Rubin highlights the genomics of plant-based biofuels in the journal Nature

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...HAM, N.C., Nov. 27 Cromoz Inc., lo...er-soluble carbon nanotube-based cancer drug deliv...carbon nanotubes, which have functional groups on ...drugs, was developed in partnership with the India... nanotubes serves as a drug delivery vehicle with ...
(Date:11/26/2009)... Ind. - A new generation of ultrasmall transistors...tures called semiconducting nanowires are closer t...IBM, Purdue University and the University of Calif...rned how to create nanowires with layers of differ...ic level, which is a critical requirement for maki...
(Date:11/25/2009)... Ambassador to Speak at Economic Club of Canad...s) November 25, 2009 -- Ambassador to Speak at Eco...French Ambassador for International Investment, an...,To view a biography of David Appia go to www.inv... available to meet with press to discuss recent pr...
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Bi...r of vaccines, announced today that it executed,a ...(Dalian) Vaccine,Technology Co., Ltd. (Sinovac Dal...ommercialize human-use vaccines. Sinovac will cont...and commercializing world-class vaccines; the,othe...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...l Therapeutics, Inc. ("CTI",or the "Company") (Nas...nstitutional investor shall purchase, for $32.65 m...due 2011 (the "Notes"), with a conversion price of...e a $32.65 million initial principal balance and,f..., upon any conversion of,the Notes, to receive the...
...Dec. 4 Researchers are taking a closer look at th...s studies continue to demonstrate that inhibiting ...orts Genetic Engineering & Biotechnology News...cell growth, differentiation, and survival. In add...ch plays a key role in cancer, according to the De...
...d, December 4 AC Immune SA, a leader,in Alzheimer...the World,Economic Forum has elected AC Immune as ... an innovation leader and for its breakthrough tec...and society. , Furthermore, AC Immune releas...ones in the development of innovative therapies ag...
Other Biology Technology:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research 2Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development 2
(Date:11/24/2009)...4, 2009) New research on bacterial communities th... predictable temporal patterns, suggesting that sc...r monitoring climate change in the polar regions. ... of the National Academy of Sciences Early Editio...ers shifted synchronously over time, correlating w...
(Date:11/23/2009)...sents strong evidence that the "synergistic" effec...elated pollution and indoor endotoxin causes more ...osure alone. , Environmental health scientists...edicine have shown that children exposed to both h... endotoxin during early life are six times more li...
(Date:11/23/2009)...mber 23, 2009 Applied mathematicians dissected th...ia ), a characteristic long leaf with a saddle-lik...the edges. The simple cause of the lily,s fan-like...ring differential growthwas revealed by using an e..., Haiyi Liang, a postdoctoral student at Harvard...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2Chindex International Inc Launches World Class Cancer Treatment Center 53897 1Chindex International Inc Launches World Class Cancer Treatment Center 53897 2Chindex International Inc Launches World Class Cancer Treatment Center 53897 3Chindex International Inc Launches World Class Cancer Treatment Center 53897 4AMN Healthcare Announces Second Quarter 2009 Results 53895 1AMN Healthcare Announces Second Quarter 2009 Results 53895 2AMN Healthcare Announces Second Quarter 2009 Results 53895 3AMN Healthcare Announces Second Quarter 2009 Results 53895 4AMN Healthcare Announces Second Quarter 2009 Results 53895 5AMN Healthcare Announces Second Quarter 2009 Results 53895 6AMN Healthcare Announces Second Quarter 2009 Results 53895 7AMN Healthcare Announces Second Quarter 2009 Results 53895 8AMN Healthcare Announces Second Quarter 2009 Results 53895 9AMN Healthcare Announces Second Quarter 2009 Results 53895 10AMN Healthcare Announces Second Quarter 2009 Results 53895 11AMN Healthcare Announces Second Quarter 2009 Results 53895 12AMN Healthcare Announces Second Quarter 2009 Results 53895 13AMN Healthcare Announces Second Quarter 2009 Results 53895 14AMN Healthcare Announces Second Quarter 2009 Results 53895 15AMN Healthcare Announces Second Quarter 2009 Results 53895 16Osteotech to Present at the Canaccord Adams 29th Annual Global Growth Conference 53893 1
... Cells become cancerous mainly because they lose ...this happens, a new study at Ohio State University... that help regulate cell growth in embryos and tha...1, E2f2, and E2f3a and E2f3b are generally believ...tion, a belief that comes from experiments using o...
...to traps that reek like latrines may be no more. ... led by chemical ecologist Walter Leal has discove...res blood-fed mosquitoes without making humans hol...g compounds trimethylamine and nonanal in low dose...current attractants, Leal said, but this one is od...
...e is available in German . , Animals "personally... partners, mating, fertilizing, and reproducing. P...the help of a third party, the pollinator, which c...n to receptive stigmas frequently over large dista...their volatile signals and nectar attract and rewa...
Other Biology News:Location, location, location important for genes, too 2No more big stink: scent lures mosquitoes, but humans can't smell it 2Bitter-tasting nectar and floral odors optimize outcrossing for plants 2Bitter-tasting nectar and floral odors optimize outcrossing for plants 3Bitter-tasting nectar and floral odors optimize outcrossing for plants 4
... the space and time dimensions of a streak camera ...e to open new horizons in biological imaging. Usi...e decay of a fluorescence emission can be captured...hanges in the local environment of a fluorescent m...
ScriptCap m7G Capping System from EPICENTRE Biotechnologies
EXTRACTI-GEL D from Pierce Biotechnology, Inc.
...speed and excellent temperature uniformity. Protoc...mocycler can be run without any modifications. The...or 96 wells. In addition, modules for 384 well pla...h Precision Smart Lid provides automatic pressure ...
Biology Products: